Your browser doesn't support javascript.
loading
The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia.
Thomé, Carolina Hassibe; Ferreira, Germano Aguiar; Pereira-Martins, Diego Antonio; Augusto Dos Santos, Guilherme; Almeida-Silveira, Douglas R; Weinhäuser, Isabel; Antônio de Souza, Gustavo; Houtsma, Roos; Schuringa, Jan Jacob; Rego, Eduardo M; Faça, Vitor M.
Afiliação
  • Thomé CH; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil.
  • Ferreira GA; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil.
  • Pereira-Martins DA; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Augusto Dos Santos G; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil.
  • Almeida-Silveira DR; Hematology Division, LIM31, Medical School of University of São Paulo, São Paulo, Brazil; Department of Hematology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Weinhäuser I; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Antônio de Souza G; Department of Immunology, Oslo University Hospital - Rikshospitalet, Oslo, Norway.
  • Houtsma R; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Schuringa JJ; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Rego EM; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Hematology Division, LIM31, Medical School of University of São Paulo, São Paulo, Brazil.
  • Faça VM; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Internal Medicine, Ribeirão Preto Medical School and Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil. Electronic address: vitor.faca
Mol Cell Proteomics ; 20: 100091, 2021.
Article em En | MEDLINE | ID: mdl-33971369

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas Adaptadoras de Transdução de Sinal Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cell Proteomics Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Proteínas Adaptadoras de Transdução de Sinal Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cell Proteomics Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil